Defective Drugs:
Bextra Linked to Heart Attack, Stevens Johnson Syndrome
Bextra
Bextra (valdecoxib) is a non-steroidal anti inflammatory drug. It was approved for use in the United States for treating arthritis pain and severe menstrual cramps in November 2001. Several reports of Bextra side effects indicate that Bextra users are at an increased risk for serious skin conditions, including Stevens Johnson Syndrome, toxic epidermal necrolysis (TEN), and erythema multiforme (EM). Stevens Johnson Syndrome is a rare inflammatory skin disorder that can be fatal in severe cases. Studies have also suggested that Bextra may be linked to an increased risk of heart attacks and strokes. Patients who have suffered serious medical problems after taking Bextra may be eligible to file a Bextra lawsuit. If you believe you might have a case, it is advisable to contact a lawyer as soon as possible. Your lawyer will help you understand your rights and determine the best course of action to take.